Current Concepts in the Management of Non-Muscle Invasive Bladder Cancer

被引：0
|
作者：
Mandhani A. [1 ]
机构：
[1] Kidney and Urology Institute, Fortis Escorts Heart Institute & Research Centre, Okhla Road, New Delhi
来源：
Indian Journal of Surgical Oncology | 2017年 / 8卷 / 3期
关键词：
Bladder cancer; High grade lamina invasive tumor; Non muscle invasive bladder cancer;
D O I：
10.1007/s13193-016-0585-2
中图分类号：
学科分类号：
摘要：
Non-muscle invasive bladder cancer, despite advances in the field of medicine, remains an enigmatic problem with no tangible solution of one-time treatment as it needs an invasive surveillance in the form of cystoscopy. There are issues related to diagnosis, ideal resection technique, BCG treatment, and follow-up. In this article, we review the recent developments in the diagnosis of the disease and describe optimal management strategies. © 2017, Indian Association of Surgical Oncology.
引用
收藏
页码：397 / 402
页数：5
相关论文
共 50 条
  • [21] Histologic subtypes of non-muscle invasive bladder cancer
    Giudici, Nicola
    Seiler, Roland
    WORLD JOURNAL OF CLINICAL ONCOLOGY, 2024, 15 (07):
  • [22] Prediction for recurrent non-muscle invasive bladder cancer
    Li, Keqiang
    Raveendran, Aravind
    Xie, Guoqing
    Zhang, Yu
    Wu, Haofan
    Huang, Zhenlin
    Jia, Zhankui
    Yang, Jinjian
    CANCER BIOMARKERS, 2023, 38 (03) : 275 - 285
  • [23] Tackling non-muscle invasive bladder cancer in the clinic
    Woldu, Solomon L.
    Sanli, Oner
    Lotan, Yair
    EXPERT REVIEW OF ANTICANCER THERAPY, 2017, 17 (05) : 467 - 480
  • [24] Investigational therapies for non-muscle invasive bladder cancer
    Smaldone, Marc C.
    Casella, Daniel P.
    Welchons, Daniel R.
    Gingrich, Jeffrey R.
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2010, 19 (03) : 371 - 383
  • [25] Diagnostic biomarkers in non-muscle invasive bladder cancer
    Faiena, Izak
    Rosser, Charles J.
    Chamie, Karim
    Furuya, Hideki
    WORLD JOURNAL OF UROLOGY, 2019, 37 (10) : 2009 - 2016
  • [26] NON-MUSCLE INVASIVE BLADDER CANCER RESISTANT TO BCG
    Turker, Polat
    Turkeri, Levent
    ARCHIVOS ESPANOLES DE UROLOGIA, 2013, 66 (09): : 833 - 840
  • [27] Immune Therapies in Non-Muscle Invasive Bladder Cancer
    Ho, Philip L.
    Williams, Stephen B.
    Kamat, Ashish M.
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2015, 16 (02)
  • [28] Valrubicin in refractory non-muscle invasive bladder cancer
    Sharma, Pranav
    Zargar-Shoshtari, Kamran
    Sexton, Wade J.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2015, 15 (12) : 1379 - 1387
  • [29] Current approaches for identifying high-risk non-muscle invasive bladder cancer
    Sanli, Oner
    Lotan, Yair
    EXPERT REVIEW OF ANTICANCER THERAPY, 2018, 18 (03) : 223 - 235
  • [30] Current Therapy and Emerging Intravesical Agents to Treat Non-Muscle Invasive Bladder Cancer
    Bree, Kelly K.
    Brooks, Nathan A.
    Kamat, Ashish M.
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2021, 35 (03) : 513 - 529
12345